Gugulipid® : Patent issued for Chemopreventive and Anti-inflammatory roles

Newsletters - OCT 2002

: 01 November 2002

US Patent 6,436,991 dated August 20, 2002, granted to Sabinsa Corporation, covers the antioxidant and cancer chemopreventive roles of constituents of Gugulipid®, the Commiphora mukul extract composition from Sabinsa Corporation. This invention, titled "Compositions for prevention and treatment of abnormal cell growth and proliferation in inflammation, neoplasia and cardiovascular disease", further unravels the multifaceted healthful benefits of this increasingly popular phytonutrient.

VISIT US

Sabinsa Europe GmbH
Monzastrasse 4
63225 Langen
Germany

+49 6103 270 11 11
+49 6103 270 11 27
info@sabinsa.eu

CERTIFICATES

GLOBAL OFFICES

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.